PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors

Category Primary study
JournalValue in Health
Year 2021
This article has no abstract
Epistemonikos ID: faa713f4ceb585d0621075df3212c199808acb50
First added on: Feb 12, 2025